683 Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-825,000
| Closed | -$19.9M | – | 291 |
|
|
2023
Q1 | $19.9M | Buy |
825,000
+275,000
| +50% | +$6.63M | 1.48% | 18 |
|
|
2022
Q4 | $5.81M | Buy |
+550,000
| New | +$5.81M | 0.49% | 49 |
|
|
2021
Q4 | – | Sell |
-198,429
| Closed | -$1.27M | – | 371 |
|
|
2021
Q3 | $1.27M | Sell |
198,429
-100,000
| -34% | -$640K | 0.05% | 124 |
|
|
2021
Q2 | $2.52M | Sell |
298,429
-331,571
| -53% | -$2.8M | 0.09% | 104 |
|
|
2021
Q1 | $6.61M | Sell |
630,000
-229,314
| -27% | -$2.41M | 0.35% | 54 |
|
|
2020
Q4 | $14.6M | Hold |
859,314
| – | – | 0.69% | 30 |
|
|
2020
Q3 | $11M | Buy |
859,314
+259,314
| +43% | +$3.33M | 0.81% | 26 |
|
|
2020
Q2 | $8.47M | Buy |
+600,000
| New | +$8.47M | 0.68% | 25 |
|
|
2020
Q1 | – | Sell |
-15,608
| Closed | -$233K | – | 185 |
|
|
2019
Q4 | $233K | Buy |
+15,608
| New | +$233K | 0.03% | 83 |
|